Similar articles for PMID: 30373742

Year	Number of Results
2000	1
2001	1
2002	2
2003	1
2004	1
2006	2
2007	1
2008	3
2009	5
2010	3
2011	10
2012	5
2013	13
2014	6
2015	12
2016	11
2017	9
2018	13
2019	11
2020	7
2021	5
2022	1
2023	1
2024	0

1

Reactivation of hepatitis B virus associated with immunosuppression therapy.

Lee JGH, Carruthers M, Ko HH. Lee JGH, et al. CMAJ. 2018 Oct 29;190(43):E1284. doi: 10.1503/cmaj.180389. CMAJ. 2018. PMID: 30373742 Free PMC article. Review. No abstract available.

2

Characteristics, Prevention, and Management of Hepatitis B Virus (HBV) Reactivation in HBV-Infected Patients Who Require Immunosuppressive Therapy.

Choi J, Lim YS. Choi J, et al. J Infect Dis. 2017 Nov 16;216(suppl_8):S778-S784. doi: 10.1093/infdis/jix178. J Infect Dis. 2017. PMID: 29156044

3

Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report.

Aygen B, Demir AM, Gümüş M, Karabay O, Kaymakoğlu S, Köksal AŞ, Köksal İ, Örmeci N, Tabak F. Aygen B, et al. Turk J Gastroenterol. 2018 May;29(3):259-269. doi: 10.5152/tjg.2018.18263. Turk J Gastroenterol. 2018. PMID: 29755010 Free PMC article.

4

[Management of hepatitis B virus reactivation during chemotherapy or immunosuppressive therapy].

Amouri A, Chtourou L, Mnif L, Tahri N. Amouri A, et al. Presse Med. 2008 Nov;37(11):1591-8. doi: 10.1016/j.lpm.2008.03.011. Epub 2008 Jun 13. Presse Med. 2008. PMID: 18555638 Review. French.

5

A retrospective cohort study of hepatitis B reactivation in patients with autoimmune bullous diseases on immunosuppressive therapy in Singapore.

Li TF, Tang-Lin L, Ang CC. Li TF, et al. J Am Acad Dermatol. 2021 Oct;85(4):1017-1020. doi: 10.1016/j.jaad.2020.12.085. Epub 2021 Jan 15. J Am Acad Dermatol. 2021. PMID: 33460715 No abstract available.

6

American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

Reddy KR, Beavers KL, Hammond SP, Lim JK, Falck-Ytter YT; American Gastroenterological Association Institute. Reddy KR, et al. Gastroenterology. 2015 Jan;148(1):215-9; quiz e16-7. doi: 10.1053/j.gastro.2014.10.039. Epub 2014 Oct 31. Gastroenterology. 2015. PMID: 25447850 Review. No abstract available.

7

American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

Perrillo RP, Gish R, Falck-Ytter YT. Perrillo RP, et al. Gastroenterology. 2015 Jan;148(1):221-244.e3. doi: 10.1053/j.gastro.2014.10.038. Epub 2014 Oct 31. Gastroenterology. 2015. PMID: 25447852 Review. No abstract available.

8

Reactivation of hepatitis B virus associated with chemotherapy and immunosuppressive agent.

Wijaya I, Hasan I. Wijaya I, et al. Acta Med Indones. 2013 Jan;45(1):61-6. Acta Med Indones. 2013. PMID: 23585411 Free article. Review.

9

Updates on management strategies of hepatitis B virus reactivation in patients with resolved hepatitis virus B infection undergoing immunosuppressive therapy in rheumatology and the current situation in Niigata Rheumatic Center.

Ito S. Ito S. Mod Rheumatol. 2021 Jul;31(4):775-782. doi: 10.1080/14397595.2020.1832731. Epub 2020 Oct 29. Mod Rheumatol. 2021. PMID: 33021133 Review.

10

Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy.

Manzano-Alonso ML, Castellano-Tortajada G. Manzano-Alonso ML, et al. World J Gastroenterol. 2011 Mar 28;17(12):1531-7. doi: 10.3748/wjg.v17.i12.1531. World J Gastroenterol. 2011. PMID: 21472116 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year